Table 2.
Patients with inflammatory bowel disease and steroid use (n = 18 030) | |||
---|---|---|---|
Side effects | Odds ratio | P‐value | Confidence interval |
Osteoporosis | 1.91 | <0.001 | 1.77–2.05 |
Other bone disorders | 1.27 | 0.271 | 0.83–1.92 |
Opportunistic infections | 2.09 | <0.001 | 1.80–2.41 |
Sepsis | 0.94 | 0.252 | 0.84–1.05 |
Acute thrombotic event | 1.48 | <0.001 | 1.34–1.64 |
Transient ischemic attack | 0.94 | 0.830 | 0.55–1.61 |
Cerebrovascular accident | 0.82 | 0.156 | 0.63–1.08 |
Myocardial infarction | 0.97 | 0.719 | 0.81–1.16 |
Diabetes mellitus | 0.93 | 0.007 | 0.88–0.98 |
Cushing's syndrome | 10.35 | <0.001 | 7.29–14.67 |
Adrenal insufficiency | 8.59 | <0.001 | 6.96–10.62 |
Metabolic syndrome | 0.99 | 0.958 | 0.96–1.03 |
Acute pancreatitis | 0.73 | 0.002 | 0.61–0.89 |
Mood disorders | 1.03 | 0.129 | 0.99–1.08 |
Drug‐induced cataract | 2.98 | 0.349 | 0.30–29.34 |
Mortality | 0.86 | 0.049 | 0.74–0.99 |